Related Experiment Videos
Infantile mitochondrial leucodystrophy - a case report
Bogna Scmidt-Sidor1, Krystyna Szymańska, Eliza Lewandowska
1Department of Neuropathology, Institute of Psychiatry and Neurology, Warszawa, Poland. neuropat@ipin.edu.pl
Folia Neuropathologica
|October 26, 2005
Summary
This case study describes an infant with leucodystrophy and Leigh syndrome, highlighting mitochondrial disease features. Autopsy revealed brain and heart abnormalities, suggesting a link between mitochondrial dysfunction and these conditions.
Area of Science:
- Pediatric Neurology
- Neuroscience
- Mitochondrial Diseases
Background:
- Leucodystrophy is a group of rare inherited disorders that affect myelin, the protective sheath of nerve fibers.
- Mitochondrial diseases are genetic disorders affecting mitochondria, the powerhouses of cells, leading to a wide range of symptoms.
Observation:
- A 7-month-old infant presented with psychomotor delay, abnormal reflexes, nystagmus, spasticity, and optic nerve atrophy.
- Clinical diagnosis was leucodystrophy, with imaging showing ventricular widening and frontal lobe atrophy. Generalized EEG changes and swallowing difficulties were noted.
- Autopsy revealed cardiac hypertrophy and orthochromatic leucodystrophy with neuropathological features of mitochondrial disease, including capillary changes, spongiosis, and brainstem damage.
Findings:
- Neuropathology indicated leucodystrophy with mitochondrial disease characteristics, specifically capillary hyperplasia, spongiosis, and symmetrical brainstem damage.
- Electron microscopy confirmed abnormal mitochondria and destruction of myelin and neurofibrils.
- The findings suggest a potential link between mitochondrial disease and cardiac hypertrophy in this case.
Implications:
- This case underscores the complex presentation of leucodystrophy and Leigh syndrome in infants.
- It highlights the importance of considering mitochondrial dysfunction in the differential diagnosis of pediatric neurological disorders with cardiac involvement.
- Further research into mitochondrial diseases is crucial for understanding and managing these devastating conditions.